Community voting is open to everyone.
Members vote once per account
, qualify for
prizes
, and see a members-only tally that is a cleaner signal.
Probiful
Markets
Live
Ideas
Calendar
Log in
Sign up
Trending
New
All
·
Pricing
Regulatory
Policy
Other
·
Watchlist
Markets
Live
Ideas
Calendar
Watchlist
Leaderboard
Trending
New
Markets
Predict healthcare events for bragging rights
1 open
Sort
Closing soon
Trending
New
50-50
Category
All
Drug pricing
Regulatory
Policy
Other
Tags
All
FDA
Launch price
PDUFA
WAC
Cingulate
Summit Therapeutics
Replimune
Achieve Life Sciences
Eton Pharmaceuticals
Shionogi
Grace Therapeutics
RP1 (vusolimogene oderparepvec) + nivolumab monthly WAC at launch?
RP1 (vusolimogene oderparepvec) + nivolumab monthly WAC at launch?
≥ $505k
50%
Yes
/
No
$480k–$505k
50%
Yes
/
No
Vote on range
< $5k
$5k–$30k
$5k–$30k
$30k–$55k
$55k–$80k
$80k–$105k
$105k–$130k
$130k–$155k
$155k–$180k
$180k–$205k
$205k–$230k
$230k–$255k
$255k–$280k
$280k–$305k
$305k–$330k
$330k–$355k
$355k–$380k
$380k–$405k
$405k–$430k
$430k–$455k
$455k–$480k
$480k–$505k
≥ $505k
Community vote
63% Yes · 8 votes
Vote
Yes - < $5k
No - < $5k
0 vol
Locks May 10, 2026